Med-tech miracle: Critical device prepping for market

It pays to be first (here's why) You are receiving this as a part of your subscription to The Startup Investor. To remove your email from this list, [unsubscribe here](. [The Startup Investor] Dear The Startup Investor Reader, Of all the amazing deals that come across our desks at the Angels & Entrepreneurs Network... None can hold a candle to our latest deal, which I believe [could be one of the most wildly profitable angel investments ever seen here](. And for several days now, I've told you about [a revolutionary medical device]( that is... - Championed by a such an elite and extraordinary startup that I've only seen two or three companies like it before... - Set to transform a $26 billion market... - In possession of a [caliber of technology that comes maybe once in a generation](. And today I'll show you, for the first time via email, one of the similar devices... So you can see why this is one of the most critical medical breakthroughs we've seen in years... Here's your first look: To your right, you'll see the first cervical disc of this type approved by the FDA. It was made by a tiny company called LDR Spine... Which was acquired for $1.1 billion in 2016. Had you been an investor in LDR's startup, you could have turned every $500 into $58,078. Let me break that down for you... that's a 116X return since 2005. The startup that I have waiting for you has the potential to have an equally dramatic return. Bottom line: It pays to be first. And it could be another generation before we see a medical device of this caliber again. [Click here to see how to enter the deal room](. Sincerely, Bob Keppel Co-Founder, Angels & Entrepreneurs Please do not reply to this email. It was sent from an unmonitored mailbox. You are receiving this e-mail at {EMAIL}, as part of your subscription to The Startup Investor. To remove your email from this list: [unsubscribe here](. To cancel, or for any other questions or requests, please contact our Customer Service team: [Online]( Phone: 866-310-1498 (North America) 443-221-6766 (International) Mail: The Startup Investor | Attn: Member Services | 1125 N Charles Street | Baltimore, MD 21201 Our Customer Service team is available Monday ‑ Friday between 9:00 AM and 5:00 PM ET. © 2021 Angels & Entrepreneurs. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of: Angels & Entrepreneurs. 1125 N Charles Street, Baltimore, MD 21201. [Website]( | [Privacy Policy]( | [Terms & Conditions](